Literature DB >> 25120812

Over-expression of p53, p21 and Cdc2 in histologically negative surgical margins is correlated with local recurrence of laryngeal squamous cell carcinoma.

Jun-Quan Yang1, Hong-Xia Liu2, Zhen Liang3, Yu-Man Sun2, Meng Wu2.   

Abstract

The aim of this study was to explore the relationship between the expression of p53, p21 and Cdc2 in the early laryngeal cancer with negative pathological margins and its local recurrence. During 2004-2010, a total of 85 patients with early laryngeal cancer were selected in Tangshan Union Hospital, Hebei, China, and immunohistochemical method was used to detect the expression of p53, p21 and Cdc2 in the negative pathological margin tissues. All patients were followed up for two years to collect pathological data for evaluating the survival and tumor recurrence. Two years after surgery 14 of 85 patients with laryngeal cancer presented with recurrence (recurrent group), while 71 patients without recurrence (none recurrent group). The positive rate of p53, p21 and Cdc2 protein in laryngeal cancer tissues was 60.0% (51/85), 38.8% (33/85) and 70.6% (60/85), respectively, while that of the three proteins in the cancer adjacent tissues was 36.5% (31/85), 21.2% (18/85) and 29.4% (25/85), respectively. The differentiation and TNM stage of tumor had no correlation with the three proteins. The positive rate of p53 in the surgical margin of the recurrent group and non recurrent group was 71.4% (10/14) and 29.6% (21/71) (P = 0.003), that of p21 was 50.0% (7/14) and 15.5% (11/71), (P = 0.011) and Cdc2 was 57.1% (8/14) and 23.9% (17/71) (P = 0.030), respectively. In conclusion, p53, p21 and Cdc2 may be involved in the occurrence, development and recurrence of laryngeal squamous cell carcinoma. Overexpression of p53, p21 and Cdc2 in the surgical margin of early laryngeal cancer is closely related to local recurrence of tumor.

Entities:  

Keywords:  Cdc2; Laryngeal squamous cell carcinoma; immunohistochemistry; local recurrence; p21; p53

Mesh:

Substances:

Year:  2014        PMID: 25120812      PMCID: PMC4129047     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma.

Authors:  B A Barrette; P J Srivatsa; W A Cliby; G L Keeney; V J Suman; K C Podratz; P C Roche
Journal:  Mayo Clin Proc       Date:  1997-10       Impact factor: 7.616

2.  Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.

Authors:  Y Ito; T Takeda; M Sakon; M Monden; M Tsujimoto; N Matsuura
Journal:  Oncology       Date:  2000-06       Impact factor: 2.935

Review 3.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

4.  Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.

Authors:  C A Nathan; K Sanders; F W Abreo; R Nassar; J Glass
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Expression of p34cdc2 protein kinase and p53 in supraglottic carcinomas.

Authors:  Y Yamamoto; T Itoh; I Inoue; H Takahashi
Journal:  Auris Nasus Larynx       Date:  1996       Impact factor: 1.863

6.  Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.

Authors:  Cherie-Ann O Nathan; Nazanin Amirghahari; Fleurette Abreo; Xiaohua Rong; Gloria Caldito; M Lamar Jones; Huijuan Zhou; Melanie Smith; Donnellan Kimberly; Jonathan Glass
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

7.  p53 overexpression on the resection margins as a marker of local recurrence in glottic T1a carcinoma.

Authors:  E Allegra; L Puzzo; D Cutrona; A Trichini; A Garozzo; A Serra
Journal:  Acta Otorhinolaryngol Ital       Date:  2003-12       Impact factor: 2.124

8.  p34cdc2 expression is an independent indicator for lymph node metastasis in colorectal carcinoma.

Authors:  T Nozoe; M Honda; S Inutsuka; D Korenaga
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-18       Impact factor: 4.553

9.  Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma.

Authors:  Shigehito Wada; Lihua Yue; Isao Furuta
Journal:  Oral Oncol       Date:  2004-02       Impact factor: 5.337

10.  Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.

Authors:  H P Kourea; A K Koutras; C D Scopa; M N Marangos; E Tzoracoeleftherakis; D Koukouras; H P Kalofonos
Journal:  Mol Pathol       Date:  2003-12
View more
  6 in total

1.  LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma.

Authors:  Xiaoxia Qiu; Yiwen You; Jianfei Huang; Xudong Wang; Huijun Zhu; Zhiwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.

Authors:  K Bednarek; K Kiwerska; M Szaumkessel; M Bodnar; M Kostrzewska-Poczekaj; A Marszalek; J Janiszewska; A Bartochowska; J Jackowska; M Wierzbicka; R Grenman; K Szyfter; M Giefing; M Jarmuz-Szymczak
Journal:  Tumour Biol       Date:  2016-02-24

3.  Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation.

Authors:  Seema Gupta; Vandana Singh Kushwaha; Sandeep Verma; Huma Khan; M L B Bhatt; Nuzhat Husain; Mahendra Pal Singh Negi; Vivek Vidyadhar Bhosale; Ashim Ghatak
Journal:  Heliyon       Date:  2016-12-05

4.  Expression level of CDC2 gene in osteosarcoma and its clinical significance.

Authors:  Gang Hou; Biying Chen; Wenbin Xu; Huiqing Zhao; Kaihua Liu; Hui Yao
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

5.  The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.

Authors:  Ruitao Zhang; Huirong Shi; Fang Ren; Minghui Zhang; Pengcheng Ji; Wenwen Wang; Chuanna Liu
Journal:  J Ovarian Res       Date:  2017-09-12       Impact factor: 4.234

6.  Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.

Authors:  Zhengyi Tang; Ganguan Wei; Longcheng Zhang; Zhiwen Xu
Journal:  Mol Med Rep       Date:  2019-04-10       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.